Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 15 results.
User Information
Export Records
  1. 1.   Antiviral activity of alpha-helical stapled peptides designed from the HIV-1 capsid dimerization domain
  2. Zhang, H. T.; Curreli, F.; Zhang, X. H.; Bhattacharya, S.; Waheed, A. A.; Cooper, A.; Cowburn, D.; Freed, E. O.; Debnath, A. K.
  3. Retrovirology. 2011, May; 8: 18.
  1. 2.   Interferon-Inducible Protein 16: Insight into the Interaction with Tumor Suppressor p53
  2. Liao, J. C. C.; Lam, R.; Brazda, V.; Duan, S. L.; Ravichandran, M.; Ma, J.; Xiao, T.; Tempel, W.; Zuo, X. B.; Wang, Y. X.; Chirgadze, N. Y.; Arrowsmith, C. H.
  3. Structure. 2011, Mar; 19(3): 418-429.
  1. 3.   Novel approaches to inhibiting HIV-1 replication
  2. Adamson, C. S.; Freed, E. O.
  3. Antiviral Research. 2010, Jan; 85(1): 119-141.
  1. 4.   Structure of the lamin A/C R482W mutant responsible for dominant familial partial lipodystrophy (FPLD)
  2. Magracheva, E.; Kozlov, S.; Stewart, C. L.; Wlodawer, A.; Zdanov, A.
  3. Acta Crystallographica Section F-Structural Biology and Crystallization Communications. 2009 65: 665-670.
  1. 5.   Transcription activation by the DNA-binding domain of the AraC family protein RhaS in the absence of its effector-binding domain
  2. Wickstrum, J. R.; Skredenske, J. M.; Kolin, A.; Jin, D. J.; Fang, J.; Egan, S. M.
  3. Journal of Bacteriology. 2007, Jul; 189(14): 4984-4993.
  1. 6.   Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy
  2. Boguslavsky, R. L.; Stewart, C. L.; Worman, H. J.
  3. Human Molecular Genetics. 2006, FEB 15; 15(4): 653-663.
  1. 7.   Molecular architecture and ligand recognition determinants for T4 RNA ligase
  2. El Omari, K.; Ren, J.; Bird, L. E.; Bona, M. K.; Klarmann, G.; Legrice, S. F. J.; Stammers, D. K.
  3. Journal of Biological Chemistry. 2006, JAN 20; 281(3): 1573-1579.
  1. 9.   Mass spectrometric analysis of the HIV-1 integrase-pyridoxal 5 '-phosphate complex reveals a new binding site for a nucleotide inhibitor
  2. Williams, K. L.; Zhang, Y. J.; Shkriabai, N.; Karki, R. G.; Nicklaus, M. C.; Kotrikadze, N.; Hess, S.; Le Grice, S. F. J.; Craigie, R.; Pathak, V. K.; Kvaratskhelia, M.
  3. Journal of Biological Chemistry. 2005, MAR 4; 280(9): 7949-7955.
  1. 10.   Photoreceptor peripherin/rds fusogenic function is inhibited by dsu, through direct binding to the C-terminal domain
  2. Boesze-Battaglia, K.; mek-Poprawa, M.; Rachel, R.; Pankoski, L.; Copeland, N.; Jenkins, N.
  3. Investigative Ophthalmology & Visual Science. 2005 46(Suppl. S): 3975-3975.
  1. 11.   Switches in bacteriophage lambda development
  2. Oppenheim, A. B.; Kobiler, O.; Stavans, J.; Court, D. L.; Adhya, S.
  3. Annual Review of Genetics. 2005 39: 409-429.
  1. 12.   RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies
  2. Kashuba, V. I.; Li, J. F.; Wang, F. L.; Senchenko, V. N.; Protopopov, A.; Malyukova, A.; Kutsenko, A. S.; Kadyrova, E.; Zabarovska, V. I.; Muravenko, O. V.; Zelenin, A. V.; Kisselev, L. L.; Kuzmin, I.; Minna, J. D.; Winberg, G.; Ernberg, I.; Braga, E.; Lerman, M. I.; Klein, G.; Zabarovsky, E. R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(14): 4906-4911.
  1. 13.   Activation of the p53 tumor suppressor protein
  2. Vousden, K. H.
  3. Biochimica Et Biophysica Acta-reviews on Cancer. 2002 1602(1): 47-59.
  1. 14.   Probing contacts between the ribonuclease H domain of HIV-1 reverse transcriptase and nucleic acid by site-specific photocross-linking
  2. Rausch, J. W.; Sathyanarayana, B. K.; Bona, M. K.; Le Grice, S. F. J.
  3. Journal of Biological Chemistry. 2000 275(21): 16015-16022.
  1. 15.   I Kappa B Epsilon, a Novel Member of the I-Kappa-B Family, Controls Rela and Crel Nf-Kappa-B Activity
  2. Whiteside, S. T.; Epinat, J. C.; Rice, N. R.; Israel, A.
  3. Embo Journal. 1997 16(6): 1413-1426.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel